feed,title,long_url,short_url
Benzinga,"GSK Says 'Excellent' Q2 Performance Boosted By Vaccine & HIV Drug Sales, Raises 2023 Outlook",https://benzinga.com/general/biotech/23/07/33385854/gsk-says-excellent-q2-performance-boosted-by-vaccine-hiv-drug-sales-raises-2023-outlook,https://da.gd/yHIYqT
Benzinga,Karyopharm's Selinexor Shows Progression-Free Survival of 27.4 Months In Endometrial Cancer With Certain Mutation,https://benzinga.com/general/biotech/23/07/33387481/karyopharms-selinexor-shows-progression-free-survival-of-27-4-months-in-endometrial-cancer-with-c,https://da.gd/RrDNrP
